Skip to main content
Premium Trial:

Request an Annual Quote

Applera Files Complaint, Notice of Arbitration Against Roche Over PCR Technology

NEW YORK, Oct. 13 (GenomeWeb News) - Applera said today that it has filed a complaint in California Superior Court, county of San Mateo, relating to disputes with Hoffman-La Roche and some of its subsidiaries over PCR technology.


Applera also said that that, in a separate action involving Roche, it has filed a notice of arbitration with the American Arbitration Association.


"Rights to PCR are part of the intellectual property estate of Applera," Applied Biosystems president Michael Hunkapiller said in a statement. "With these actions, Applera is seeking to protect its rights to PCR and obtain fair value from these rights."


Applera has licenses from Roche to certain PCR intellectual property, and markets TaqMan products that use Roche-designed PCR technology.


An Applera spokeswoman declined to comment on the matter.  Officials from Roche were unavailable.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.